Stonehaven
Founded in 2001, Stonehaven is a global FinTech platform facilitating private capital markets for investment bankers and placement agents. It serves clients across various sectors including real estate, private equity, venture capital, and others.
1 past transactions
Response Pharmaceuticals
Series A in 2022
Response Pharmaceuticals is a biotechnology company developing treatments for cardiometabolic risk factors associated with antipsychotic drugs. Its primary focus is on managing post-prandial triglyceride levels, body weight, and other related health issues in patients discontinuing semaglutide or tirzepatide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.